11 Sep 2018 by admin in UncategorizedComments Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer
06 Sep 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces CNTX-4975 Data Presentation at PAINWeek 2018 National Conference
04 Sep 2018 by admin in UncategorizedComments TEMPEST THERAPEUTICS NAMES DR. GINNA LAPORT CMO – Dr. Alicia Levey promoted to CBO –
15 Aug 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Dan Mendelson to its Board of Directors
15 Aug 2018 by admin in UncategorizedComments resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors
14 Aug 2018 by admin in UncategorizedComments Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda
09 Aug 2018 by admin in UncategorizedComments resTORbio Reports Second Quarter 2018 Financial Results
07 Aug 2018 by admin in UncategorizedComments Syros Reports Second Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
31 Jul 2018 by admin in UncategorizedComments Syros to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
30 Jul 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Financial Executive Nick Harvey as Chief Financial Officer
